LEGA Trial

LowtoxEoxGastricAdvanced

A RANDOMIZED PHASE III STUDY OF LOW-DOCETAXEL OXALIPLATIN, CAPECITABINE (LOW-TOX) VS EPIRUBICIN, OXALIPLATIN AND CAPECITABINE (EOX) IN PATIENTS WITH LOCALLY ADVANCED UNRESECTABLE OR METASTATIC GASTRIC CANCER

ESMO CONGRESS

BARCELLONA 27 SETTEMBRE - 1 OTTOBRE 2019

AIOM CONGRESS

ROMA 25 - 26 - 27 OTTOBRE 2019

Scarica il file